Hematology/Oncology

Top Story

Tasquinimod prolongs radiographic PFS, not OS, in metastatic prostate cancer

July 28, 2016

Tasquinimod significantly improved radiographic PFS in men with chemotherapy-naive, metastatic castration-resistant prostate cancer, according to the results of a randomized controlled trial.

However, the agent did not confer an OS benefit, results showed.

In the Journals Plus

Online communication helps treatment decisions following breast cancer diagnosis

July 28, 2016
Women who engaged with social medial following their breast cancer diagnosis reported more deliberation and satisfaction with their treatment decisions, according to…
In the Journals Plus

Elective neck dissection reduces regional recurrence in node-negative oral tongue carcinoma

July 28, 2016
Elective neck dissection reduced risk for regional node recurrence and improved disease-specific survival compared with management and observation among patients with…
In the Journals

Use of EHRs, CPOE associated with physician burnout, dissatisfaction

July 27, 2016
Physicians reported low satisfaction with their electronic health records and computerized physician order entry, according to findings published in Mayo Clinic
Health Care Legislative and Regulatory Update

Are the holiday baskets really worth the risk?

July 27, 2016
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
More News Headlines »
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Video
Meeting News Coverage

VIDEO: Adding rituximab to chemotherapy increases PFS in patients with CLL

July 8, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan